Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN
- 20 November 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 16 (5) , 796-803
Abstract
Background: It is still of debate whether the advent of biologics has been associated with a change in the natural history of ulcerative colitis [UC]. In this nationwide study we evaluated trends of long-term outcomes in all patients diagnosed with UC in Israel during the biologic era.Methods: Data in the epi-IIRN cohort were retrieved from the four Israeli Health Maintenance Organizations covering 98% of the population, and linked to the Ministry of Health prospective registry on surgeries and hospitalizations. Joinpoint Regression and Kaplan–Meier survival analyses were used, reporting annual average percentage change [AAPC] for each outcome.Results: A total of 13 231 patients were diagnosed with UC since 2005 (1426 [11%] paediatric-onset, 10 310 [78%] adults, 1495 [11%] elderly) with 93 675 person-years of follow-up. The probabilities of surgery after 1, 3 and 5 years from diagnosis were 1.1, 2.3 and 4.1%, respectively, and the corresponding rates of hospitalizations were 22, 33 and 41%. The overall utilization of biologics in UC increased from 0.1% in 2005 to 9.6% in 2019 [AAPC 22.1%] and they were prescribed earlier during the disease course (median of 5.6 years [interquartile range 2.8–9.1] in 2005–2008 vs 0.8 years [0.4–1.5] in 2015–2018; p < 0.001]. Annual rates of surgeries [AAPC −1.3; p = 0.6] and steroid-dependency [AAPC −1.2; p = 0.3] remained unchanged, while rates of hospitalizations slightly decreased [AAPC −1.2; p < 0.001]. Outcomes were consistently worse in paediatric-onset disease than in adults, despite higher utilization of biologics [28% vs 12%, respectively; p < 0.001].Conclusion: During the biologic era rates of surgeries and steroid-dependency have remained unchanged in patients with UC, while rates of hospitalizations have slightly decreased.Keywords
This publication has 18 references indexed in Scilit:
- Restorative surgery after colectomy for ulcerative colitis in England and Sweden: observations from a comparison of nationwide cohortsColorectal Disease, 2018
- Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort StudyJournal of Crohn's and Colitis, 2018
- Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic ReviewClinical Gastroenterology and Hepatology, 2018
- Changes in medical management and colectomy rates: a population‐based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963‐2010Alimentary Pharmacology & Therapeutics, 2017
- As Infliximab Use for Ulcerative Colitis Has Increased, so Has the Rate of Surgical ResectionJournal of Gastrointestinal Surgery, 2017
- Systematic review with meta‐analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitisAlimentary Pharmacology & Therapeutics, 2016
- Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn’s DiseaseJournal of Crohn's and Colitis, 2016
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2004
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000